US equities |
NVDA $178.67 ▼-4.27% AMD $508.58 ▲+13.26% MU $733.15 ▲+6.25% AAPL $350.69 ▲+2.43% SPCX $142.07 ▲+5.81% MSFT $545.18 ▲+2.75% AMZN $266.93 ▲+2.94% TSLA $378.05 ▲+5.54%
FinancialContent

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

11.05 +0.60 (+5.74%)
Delayed Quote Updated: 4:00 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Via AB Newswire
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway ↗
DBV Technologies progresses with regulatory efforts for its Viaskin Peanut patch in the U.S. and Europe, while financial concerns loom as the company seeks additional funding to continue its... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q2 2024 ↗
DBVT stock results show that DBV Technologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming EAACI 2024 Congress
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Results of its 2024 Combined General Meeting
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
DBV Technologies to Participate in Upcoming Investor Conferences
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q1 2024 ↗
DBVT stock results show that DBV Technologies beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Combined General Meeting of May 16, 2024
From DBV Technologies S.A.
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >